Streetbeat News

Price Targets

TGAN

B. Riley Securities analyst Craig Ellis has maintained a Neutral rating on Transphorm (NASDAQ:TGAN) and lowered the price target from $4.5 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 3:16 pm

VERV

Guggenheim analyst Seamus Fernandez maintains a Buy rating on Verve Therapeutics (NASDAQ:VERV) but lowers the price target from $56 to $55.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 3:09 pm

OPRX

Lake Street analyst Eric Martinuzzi has maintained a 'Buy' rating on OptimizeRx (NASDAQ:OPRX) but lowered the price target from $18 to $13.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 3:08 pm

OPRX

Roth MKM analyst Richard Baldry has maintained a 'Buy' rating on OptimizeRx (NASDAQ:OPRX) but lowered the price target from $31 to $20.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 3:06 pm

VIRI

Zacks Small-Cap Research has set a price valuation of $3.50 for Virios Therapeutics. This valuation is highly dependent on the continued clinical success of IMC-1 and will be adjusted based on future clinical results.

Portfolio Pulse from Happy Mohamed

August 15, 2023 | 3:06 pm

TSX:PBH

RBC Capital analyst Sabahat Khan maintains a 'Sector Perform' rating on Premium Brands Holdings (TSX:PBH) and raises the price target from C$104 to C$110.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 3:04 pm

ONCY

RBC Capital analyst Douglas Miehm has reiterated an 'Outperform' rating on Oncolytics Biotech (TSX:ONC) and maintained a C$6 price target.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 3:03 pm

TSX:NXR

RBC Capital analyst Pammi Bir has maintained a 'Sector Perform' rating on Nexus Ind REIT (TSX:NXR) but lowered the price target from C$11 to C$10.5.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 3:02 pm

MNDY

DA Davidson analyst Robert Simmons maintains a Neutral rating on Monday.Com (NASDAQ:MNDY) and raises the price target from $160 to $170.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 3:02 pm

TSX:EGLX

RBC Capital analyst Drew McReynolds has reiterated his 'Outperform' rating on Enthusiast Gaming Hldgs (TSX:EGLX), maintaining a price target of C$3.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 3:01 pm